These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29061982)

  • 21. Expression of enhancer of zeste homolog 2 correlates with survival outcome in patients with metastatic breast cancer: exploratory study using primary and paired metastatic lesions.
    Inari H; Suganuma N; Kawachi K; Yoshida T; Yamanaka T; Nakamura Y; Yoshihara M; Nakayama H; Yamanaka A; Masudo K; Oshima T; Yokose T; Rino Y; Shimizu S; Miyagi Y; Masuda M
    BMC Cancer; 2017 Feb; 17(1):160. PubMed ID: 28241804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The potential of EZH2 expression to facilitate treatment choice in stage II colorectal adenocarcinoma.
    Zhu X; He L; Zheng Z; Wang Y; Yang J; Zhang B; Wang C; Li Z
    Histol Histopathol; 2024 Oct; 39(10):1371-1379. PubMed ID: 38567631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hotair mediates tumorigenesis through recruiting EZH2 in colorectal cancer.
    Huang KB; Zhang SP; Zhu YJ; Guo CH; Yang M; Liu J; Xia LG; Zhang JF
    J Cell Biochem; 2019 Apr; 120(4):6071-6077. PubMed ID: 30362162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancer of zeste homolog 2 (EZH2) regulates tumor angiogenesis and predicts recurrence and prognosis of intrahepatic cholangiocarcinoma.
    Nakagawa S; Okabe H; Ouchi M; Tokunaga R; Umezaki N; Higashi T; Kaida T; Arima K; Kitano Y; Kuroki H; Mima K; Nitta H; Imai K; Hashimoto D; Yamashita YI; Chikamoto A; Baba H
    HPB (Oxford); 2018 Oct; 20(10):939-948. PubMed ID: 29759640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancer of zeste 2 polycomb repressive complex 2 subunit promotes sorafenib resistance of hepatocellular carcinoma though insulin-like growth factor 1 receptor.
    Hu J; Zhang J; Sun F; Qi M; Su P; Liu H; Gao L; Jiao M; Wu Z; Xiang L; Han B
    Anticancer Drugs; 2019 Aug; 30(7):e0746. PubMed ID: 31305292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancer of zeste homolog 2 overexpression in nasopharyngeal carcinoma: an independent poor prognosticator that enhances cell growth.
    Hwang CF; Huang HY; Chen CH; Chien CY; Hsu YC; Li CF; Fang FM
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):597-604. PubMed ID: 21300475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ZMYND8 preferentially binds phosphorylated EZH2 to promote a PRC2-dependent to -independent function switch in hypoxia-inducible factor-activated cancer.
    Tang B; Sun R; Wang D; Sheng H; Wei T; Wang L; Zhang J; Ho TH; Yang L; Wei Q; Huang H
    Proc Natl Acad Sci U S A; 2021 Feb; 118(8):. PubMed ID: 33593912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancer of zeste homolog 2 as an independent prognostic marker for cancer: a meta-analysis.
    Chen S; Huang L; Sun K; Wu D; Li M; Li M; Zhong B; Chen M; Zhang S
    PLoS One; 2015; 10(5):e0125480. PubMed ID: 25974088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression.
    Yang L; Ma DW; Cao YP; Li DZ; Zhou X; Feng JF; Bao J
    Theranostics; 2021; 11(8):3742-3759. PubMed ID: 33664859
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition of EZH2 expression is associated with the proliferation, apoptosis, and migration of SW620 colorectal cancer cells in vitro.
    He SB; Zhou H; Zhou J; Zhou GQ; Han T; Wan DW; Gu W; Gao L; Zhang Y; Xue XF; Zhang LF; Fei M; Hu SQ; Yang XD; Zhu XG; Wang L; Li DC
    Exp Biol Med (Maywood); 2015 Apr; 240(4):458-66. PubMed ID: 25005166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ubiquitous expressed transcript promotes tumorigenesis by acting as a positive modulator of the polycomb repressive complex 2 in clear cell renal cell carcinoma.
    Zeng J; Xiang W; Zhang Y; Huang C; Chen K; Chen Z
    BMC Cancer; 2019 Sep; 19(1):874. PubMed ID: 31481081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SNHG6 Promotes Tumor Growth via Repression of P21 in Colorectal Cancer.
    Li Z; Qiu R; Qiu X; Tian T
    Cell Physiol Biochem; 2018; 49(2):463-478. PubMed ID: 30157475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EZH2 overexpression in head and neck cancer is related to lymph node metastasis.
    Nienstedt JC; Schroeder C; Clauditz T; Simon R; Sauter G; Muenscher A; Blessmann M; Hanken H; Pflug C
    J Oral Pathol Med; 2018 Mar; 47(3):240-245. PubMed ID: 29285811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low expression levels of microRNA-124-5p correlated with poor prognosis in colorectal cancer via targeting of SMC4.
    Jinushi T; Shibayama Y; Kinoshita I; Oizumi S; Jinushi M; Aota T; Takahashi T; Horita S; Dosaka-Akita H; Iseki K
    Cancer Med; 2014 Dec; 3(6):1544-52. PubMed ID: 25081869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant expression of enhancer of zeste homologue 2, correlated with HIF-1α, refines relapse risk and predicts poor outcome for breast cancer.
    Dong M; Fan XJ; Chen ZH; Wang TT; Li X; Chen J; Lin Q; Wen JY; Ma XK; Wei L; Ruan DY; Lin ZX; Liu Q; Wu XY; Wan XB
    Oncol Rep; 2014 Sep; 32(3):1101-7. PubMed ID: 25017254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncogenic enhancer of zeste homolog 2 is an actionable target in patients with non-small cell lung cancer.
    Shi B; Behrens C; Vaghani V; Riquelme EM; Rodriguez-Canales J; Kadara H; Lin H; Lee J; Liu H; Wistuba I; Simon G
    Cancer Med; 2019 Oct; 8(14):6383-6392. PubMed ID: 31456359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carcinogenic roles and therapeutic effects of EZH2 in gynecological cancers.
    Wan Z; Jiang H; Li L; Zhu S; Hou J; Yu Y
    Bioorg Med Chem; 2020 Apr; 28(7):115379. PubMed ID: 32098708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of high EZH2 expression in patients with different types of cancer: a systematic review with meta-analysis.
    Jiang T; Wang Y; Zhou F; Gao G; Ren S; Zhou C
    Oncotarget; 2016 Jan; 7(4):4584-97. PubMed ID: 26683709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of the correlation between Zeste enhancer homolog 2 (EZH2) mRNA expression and the prognosis of mesothelioma patients and immune infiltration.
    Fan K; Zhang CL; Zhang BH; Gao MQ; Sun YC
    Sci Rep; 2022 Oct; 12(1):16583. PubMed ID: 36195655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancer of zeste homologue 2 plays an important role in neuroblastoma cell survival independent of its histone methyltransferase activity.
    Bate-Eya LT; Gierman HJ; Ebus ME; Koster J; Caron HN; Versteeg R; Dolman MEM; Molenaar JJ
    Eur J Cancer; 2017 Apr; 75():63-72. PubMed ID: 28214660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.